{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:56:13Z","timestamp":1791244573301,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jormas.2026.102722","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:46:37Z","timestamp":1768520797000},"page":"102722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of immunotherapy in the management of oral squamous cell carcinoma \u2013 A systematic review"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4821-9667","authenticated-orcid":false,"given":"Anusree","family":"J","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5345-954X","authenticated-orcid":false,"given":"Easwaran","family":"Ramaswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4426-3411","authenticated-orcid":false,"given":"Sonali","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5515-1883","authenticated-orcid":false,"given":"Vijayalaxmi","family":"Nimma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5601-8180","authenticated-orcid":false,"given":"Siddhi","family":"Rane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jormas.2026.102722_bib0001","first-page":"1","article-title":"Re-defining oral squamous cell carcinoma","volume":"7","author":"Chettiankandy","year":"2022","journal-title":"IP J Diagn Pathol Oncol"},{"key":"10.1016\/j.jormas.2026.102722_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105451","article-title":"Overview of oral cavity squamous cell carcinoma: risk factors, mechanisms, and diagnostics","volume":"121","author":"Chamoli","year":"2021","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jormas.2026.102722_bib0003","first-page":"76","article-title":"Novel immunotherapeutic approaches in head and neck cancer","volume":"5","author":"Neal","year":"2019","journal-title":"Cancer Metastasis Treat"},{"issue":"2","key":"10.1016\/j.jormas.2026.102722_bib0004","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4103\/0973-029X.325257","article-title":"Immunotherapy: the future of cancer treatment","volume":"25","author":"Sahu","year":"2021","journal-title":"J Oral Maxillofac Pathol"},{"issue":"Suppl 2","key":"10.1016\/j.jormas.2026.102722_bib0005","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.4103\/JPBS.JPBS_31_19","article-title":"Immunotherapy in oral cancer","volume":"11","author":"Mohan","year":"2019","journal-title":"J Pharm Bioallied Sci"},{"key":"10.1016\/j.jormas.2026.102722_bib0006","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jormas.2026.102722_bib0007","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"bmj"},{"key":"10.1016\/j.jormas.2026.102722_bib0008","unstructured":"Mendeley- Available from: https:\/\/www.mendeley.com\/reference-management\/reference-manager\/)"},{"key":"10.1016\/j.jormas.2026.102722_bib0009","series-title":"JBI manual for evidence synthesis","article-title":"Chapter 7: systematic reviews of etiology and risk","author":"Moola","year":"2020"},{"issue":"10","key":"10.1016\/j.jormas.2026.102722_bib0010","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI evid synth"},{"key":"10.1016\/j.jormas.2026.102722_bib0011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1758-3284-2-3","article-title":"Rapid palliation of symptoms with platinum-based chemotherapy plus cetuximab in recurrent oral cancer: a case report","volume":"2","author":"Mes\u00eda","year":"2010","journal-title":"Head Neck Oncol"},{"issue":"1","key":"10.1016\/j.jormas.2026.102722_bib0012","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000485562","article-title":"Successful treatment of refractory squamous cell cancer of the head and neck with Nivolumab and Ipilimumab","volume":"11","author":"Schwab","year":"2018","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.jormas.2026.102722_bib0013","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.12659\/AJCR.910224","article-title":"The role of immunotherapy and radiation therapy in tumor chemosensitivity in advanced head and neck cancer","volume":"19","author":"Atiq","year":"2018","journal-title":"Am J Case Rep"},{"issue":"6","key":"10.1016\/j.jormas.2026.102722_bib0014","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.21037\/apm-20-1485","article-title":"Complete and enduring response in an elderly patient with repeated recurrent gingival squamous cell carcinoma treated by combined toripalimab and single agent chemotherapy: a case report","volume":"10","author":"Wu","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"4","key":"10.1016\/j.jormas.2026.102722_bib0015","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1200\/JCO.22.01408","article-title":"Immunotherapy, chemotherapy, or both: options for first-line therapy for patients with recurrent or metastatic head and neck squamous cell carcinoma","volume":"41","author":"Ho","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jormas.2026.102722_bib0016","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13014-023-02282-9","article-title":"Efficacy of concurrent chemoradiotherapy with retrograde super selective intra-arterial infusion combined with cetuximab for synchronous multifocal oral squamous cell carcinomas","volume":"18","author":"Chen","year":"2023","journal-title":"Radiat Oncol"},{"issue":"31","key":"10.1016\/j.jormas.2026.102722_bib0017","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033797","article-title":"Pseudoprogression in the era of immunotherapy-based strategies for recurrent head and neck squamous cell carcinoma achieving complete response: a case report","volume":"102","author":"Zhou","year":"2023","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.jormas.2026.102722_bib0018","doi-asserted-by":"crossref","first-page":"e8219","DOI":"10.1002\/ccr3.8219","article-title":"Successful treatment with nivolumab in a patient with unresectable oral squamous cell carcinoma following ineffective chemoradiotherapy","volume":"11","author":"Sekido","year":"2023","journal-title":"Clin Case Rep"},{"issue":"1","key":"10.1016\/j.jormas.2026.102722_bib0019","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1186\/s12903-024-04683-y","article-title":"Chronic nonspecific cheilitis associated with tislelizumab treatment in a patient with a history of tongue squamous cell carcinoma: a case report","volume":"24","author":"Yu","year":"2024","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.jormas.2026.102722_bib0020","doi-asserted-by":"crossref","unstructured":"Polanowski P., Howorus M., Nasiek A., Kozub A., Pietruszka A., Drosik-Rutowicz K., Polanowska K., Sk\u0142adowski K. Long-term survival after stereotactic radiotherapy combined with immunotherapy in a patient with recurrent oral cancer. Case Rep oncol. 2024 Dec 6;17(1):1366\u201373. doi: 10.1159\/000542321. PMID: 39650716; PMCID: PMC11623968.","DOI":"10.1159\/000542321"},{"issue":"1","key":"10.1016\/j.jormas.2026.102722_bib0021","article-title":"Pulmonary tuberculosis following immune checkpoint inhibitor treatment for recurrent maxillary squamous cell carcinoma","volume":"16","author":"Kikuta","year":"2024","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.jormas.2026.102722_bib0022","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231202140","article-title":"Relapse of lupus nephritis induced by nivolumab in an 84-year-old patient with oral cancer: a case report","volume":"51","author":"Zhou","year":"2023","journal-title":"J Int Med Res"},{"issue":"6","key":"10.1016\/j.jormas.2026.102722_bib0023","doi-asserted-by":"crossref","DOI":"10.5070\/D3246040713","article-title":"Striking enhancement at the site of radiation for nivolumab-induced Stevens-Johnson syndrome","volume":"24","author":"Shah","year":"2018","journal-title":"Dermatol Online J"},{"issue":"9","key":"10.1016\/j.jormas.2026.102722_bib0024","article-title":"Digital ulcerative lichenoid dermatitis in a patient receiving anti-PD-1 therapy","volume":"25","author":"\u00c1","year":"2019","journal-title":"Dermatol Online J"},{"issue":"10","key":"10.1016\/j.jormas.2026.102722_bib0025","article-title":"Alpelisib and immunotherapy: a promising combination for recurrent and metastatic squamous cell carcinoma of the head and neck","volume":"7","author":"Suleiman","year":"2024","journal-title":"Cancer Rep (Hob)"},{"issue":"12","key":"10.1016\/j.jormas.2026.102722_bib0026","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.3390\/curroncol30120767","article-title":"Treatment response of gingival squamous-cell carcinoma to palliative intent immunotherapy","volume":"30","author":"Trehan","year":"2023","journal-title":"Curr Oncol"},{"issue":"38","key":"10.1016\/j.jormas.2026.102722_bib0027","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034660","article-title":"Efficacy of first-line immunization combined with antiangiogenesis treatment and chemotherapy for the treatment of tongue cancer: a case report","volume":"102","author":"Zhao","year":"2023","journal-title":"Medicine"},{"issue":"155489","key":"10.1016\/j.jormas.2026.102722_bib0028","article-title":"Comprehensive insights into oral squamous cell carcinoma: diagnosis, pathogenesis, and therapeutic advances","volume":"261","author":"Jagadeesan","year":"2024","journal-title":"Pathol Res Pr"},{"key":"10.1016\/j.jormas.2026.102722_bib0029","article-title":"Immunotherapy in oral cancer","author":"Rajeev","year":"2024","journal-title":"J Mar Med Soc"},{"key":"10.1016\/j.jormas.2026.102722_bib0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12903-020-01192-6","article-title":"Analysis of primary oral and oropharyngeal squamous cell carcinoma in inhabitants of Beijing, China\u2014A 10-year continuous single-center study","volume":"20","author":"Bai","year":"2020","journal-title":"BMC Oral Health"},{"issue":"19","key":"10.1016\/j.jormas.2026.102722_bib0032","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jormas.2026.102722_bib0033","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jormas.2026.102722_bib0034","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"issue":"10167","key":"10.1016\/j.jormas.2026.102722_bib0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"KEYNOTE-040 investigators. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jormas.2026.102722_bib0036","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.220037","article-title":"Pseudoprogression during immunotherapy in metastatic head and neck squamous cell carcinoma","volume":"4","author":"Bedmutha","year":"2022","journal-title":"Radiol Imaging Cancer"},{"key":"10.1016\/j.jormas.2026.102722_bib0037","doi-asserted-by":"crossref","unstructured":"Alberti A., Lorini L., Ravanelli M., Perri F., Vinches M., Rondi P., Romani C., Bossi P. New challenges in evaluating outcomes after immunotherapy in recurrent and\/or metastatic head and neck squamous cell carcinoma. Vaccines (Basel). 2022 Jun 1;10(6):885. doi: 10.3390\/vaccines10060885. PMID: 35746493; PMCID: PMC9228441.","DOI":"10.3390\/vaccines10060885"},{"key":"10.1016\/j.jormas.2026.102722_bib0038","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918764628","article-title":"Clinical assessment of immune-related adverse events","volume":"10","author":"Sosa","year":"2018","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"10.1016\/j.jormas.2026.102722_bib0039","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with Immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785526000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785526000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:11:02Z","timestamp":1784531462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468785526000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2468785526000157"],"URL":"https:\/\/doi.org\/10.1016\/j.jormas.2026.102722","relation":{},"ISSN":["2468-7855"],"issn-type":[{"value":"2468-7855","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of immunotherapy in the management of oral squamous cell carcinoma \u2013 A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Stomatology Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jormas.2026.102722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102722"}}